Keith Borkett

Title: The Innovative Mind of Keith Borkett

Introduction

Keith Borkett, an accomplished inventor based in Houghton Camps, GB, holds a total of 8 patents. His innovative contributions to the field of medicine have notably focused on sedation methods, making significant advancements in patient care.

Latest Patents

One of Keith's latest inventions is a dosing regimen for sedation utilizing CNS 7056 (Remimazolam). This fast-acting benzodiazepine, when combined with an opioid such as fentanyl, presents a well-defined dosing strategy. The recommended dosage for CNS 7056 ranges from 2 to 20 mg, with a preferred range between 4 and 9 mg, and most ideally between 5 and 8 mg. This invention not only streamlines the sedation process but also potentially enhances patient outcomes during medical procedures.

Career Highlights

Keith Borkett works at Paion UK Limited, where he contributes to pioneering research and development in pharmaceutical innovations. His work has earned him recognition within the industry and has contributed to the advancement of medical practices.

Collaborations

In his career, Keith has collaborated with notable colleagues, including Karin Wilhelm-Ogunbiyi and Gary Stuart Tilbrook. These partnerships have allowed him to enhance his research efforts and broaden the impact of his inventions within the medical community.

Conclusion

Keith Borkett stands out as a remarkable inventor in the field of medicine, especially with his contributions revolving around sedation techniques. His ongoing work at Paion UK Limited, along with his collaborative spirit, indicates a promising future filled with further innovations that could benefit both healthcare providers and patients alike.